The amount of ROS is an important factor for cell death caused by PDT, so we used DCFH-DA fluorescent probe to label ROS, and Annexin V-FITC assay confirmed that both PDT and SUR could produce higher concentration of ROS with the increase of dose in CCA cells (Figure 2D). The gene discussed is ANXA5; the disease is cholangiocarcinoma.